Tony,
I should have added that directly following Watts presentation is a presentation by Dr Timmerman from Pepscan Therapeutics titled Peptide Lead Optimisation using Solid-Phase Peptide Arrays.
You have spoken about synthetic array libraries so I know you would be particularly interested.
Interesting to re-quote Dr Wim Mol CEO of Pepscan from 10 May 2011;
"[Pepscan] therefore believes that this agreement [with Phylogica in relation to peptide lead optimisation] only forms the start of a promising and productive relationship between our two companies."
Wayne.
Tony,I should have added that directly following Watts...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |